Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Reboxetine for treatment obsessive compulsive disorders and panic disorder

Reboxetine for treatment obsessive compulsive disorders and panic disorder

US Patent 6391876 · Granted May 21, 2002

Estimated economic value: $96,357,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Heterocyclic inhibitors of MCT42025
Implant injector device2025
Aqueous oral pharmaceutical suspension compositions2025
MCT4 inhibitors for treating disease2025
Intracanalicular depot inserter device2024
Non-hormonal steroid modulators of NF-kB for treatment of disease2023
Inhibitors of dihydroceramide desaturase for treating disease2023
KDM1A inhibitors for the treatment of disease2023
MCT4 inhibitors for treating disease2023
Non-hormonal steroid modulators of NF-κβ for treatment of disease2023
Acid addition salts, compositions, and methods of treating2023
KDM1A inhibitors for the treatment of disease2023